Abstract
c-Myc drives uncontrolled cell proliferation in various human cancers. However, in mouse embryo fibroblasts (MEFs), c-Myc also induces apoptosis by activating the p19Arf tumor suppressor pathway. Tbx2, a transcriptional repressor of p19Arf, can collaborate with c-Myc by suppressing apoptosis. MEFs overexpressing c-Myc and Tbx2 are immortal but not transformed. We have performed an unbiased genetic screen, which identified 12 oncogenes that collaborate with c-Myc and Tbx2 to transform MEFs in vitro. One of them encodes the LPA2 receptor for the lipid growth factor lysophosphatidic acid (LPA). We find that LPA1 and LPA4, but not LPA3, can reproduce the transforming effect of LPA2. Using pharmacological inhibitors, we show that the in vitro cell transformation induced by LPA receptors is dependent on the Gi-linked ERK and PI3K signaling pathways. The transforming ability of LPA1, LPA2 and LPA4 was confirmed by tumor formation assays in vivo and correlated with prolonged ERK1/2 activation in response to LPA. Our results reveal a direct role for LPA receptor signaling in cell transformation and tumorigenesis in conjunction with c-Myc and reduced p19Arf expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adhikary S, Eilers M . (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635–645.
Benito M, Lorenzo M . (1993). Platelet derived growth factor/tyrosine kinase receptor mediated proliferation. Growth Regul 3: 172–179.
Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, Guglielmi J et al. (2004). Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 114: 1714–1725.
Bowe MA, Fallon JR . (1995). The role of agrin in synapse formation. Annu Rev Neurosci 18: 443–462.
Datta A, Nag A, Pan W, Hay N, Gartel AL, Colamonici O et al. (2004). Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. J Biol Chem 279: 36698–36707.
Ding Z, Liang J, Lu Y, Yu Q, Songyang Z, Lin SY et al. (2006). A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners. Proc Natl Acad Sci USA 103: 15014–15019.
Drayton S, Rowe J, Jones R, Vatcheva R, Cuthbert-Heavens D, Marshall J et al. (2003). Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell 4: 301–310.
Erickson JR, Hasegawa Y, Fang X, Eder A, Mao M, Furui T et al. (2001). Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management. Prostaglandins 64: 63–81.
Fu L, Qin YR, Xie D, Chow HY, Ngai SM, Kwong DL et al. (2007). Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. Cancer 110: 2672–2681.
Gil J, Peters G . (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667–677.
Heidecker G, Huleihel M, Cleveland JL, Kolch W, Beck TW, Lloyd P et al. (1990). Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol 10: 2503–2512.
Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H et al. (1998). Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 140: 1383–1393.
Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F et al. (2005). Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 128: 51–62.
Huang MC, Lee HY, Yeh CC, Kong Y, Zaloudek CJ, Goetzl EJ . (2004). Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). Oncogene 23: 122–129.
Ishii I, Contos JJ, Fukushima N, Chun J . (2000). Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol Pharmacol 58: 895–902.
Ishii I, Fukushima N, Ye X, Chun J . (2004). Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 73: 321–354.
Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM et al. (2000). Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 26: 291–299.
Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M . (1999). Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13: 2678–2690.
Jaffe AB, Hall A . (2005). Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21: 247–269.
Jones SM, Kazlauskas A . (2001). Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat Cell Biol 3: 165–172.
Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L et al. (1996). Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol 16: 3923–3933.
Koh EY, Chen T, Daley GQ . (2002). Novel retroviral vectors to facilitate expression screens in mammalian cells. Nucleic Acids Res 30: e142.
Kostenko EV, Mahon GM, Cheng L, Whitehead IP . (2005). The Sec14 homology domain regulates the cellular distribution and transforming activity of the Rho-specific guanine nucleotide exchange factor Dbs. J Biol Chem 280: 2807–2817.
Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J et al. (2007). p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448: 943–946.
Land H, Chen AC, Morgenstern JP, Parada LF, Weinberg RA . (1986). Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol 6: 1917–1925.
Land H, Parada LF, Weinberg RA . (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602.
Lee CW, Rivera R, Dubin AE, Chun J . (2007). LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. J Biol Chem 282: 4310–4317.
Lee CW, Rivera R, Gardell S, Dubin AE, Chun J . (2006a). GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 281: 23589–23597.
Lee Z, Swaby RF, Liang Y, Yu S, Liu S, Lu KH et al. (2006b). Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res 66: 2740–2748.
Lingbeek ME, Jacobs JJ, van Lohuizen M . (2002). The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 277: 26120–26127.
Mills GB, Moolenaar WH . (2003). The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582–591.
Moolenaar WH, van Meeteren LA, Giepmans BN . (2004). The ins and outs of lysophosphatidic acid signaling. Bioessays 26: 870–881.
Noguchi K, Ishii S, Shimizu T . (2003). Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278: 25600–25606.
O’regan L, Blot J, Fry AM . (2007). Mitotic regulation by NIMA-related kinases. Cell Div 2: 25.
Pasternack SM, von Kugelgen I, Aboud KA, Lee YA, Ruschendorf F, Voss K et al. (2008). G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 40: 329–334.
Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A . (2003). PDGF receptors as cancer drug targets. Cancer Cell 3: 439–443.
Prince S, Carreira S, Vance KW, Abrahams A, Goding CR . (2004). Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res 64: 1669–1674.
Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR . (2004). p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431: 712–717.
Ramjaun AR, Downward J . (2007). Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis. Cell Cycle 6: 2902–2905.
Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ et al. (1994). Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527–532.
Seoane J, Le HV, Massague J . (2002). Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729–734.
Sherr CJ . (2004). Principles of tumor suppression. Cell 116: 235–246.
Sherr CJ . (2006). Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6: 663–673.
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ . (2000). Understanding Ras: ‘it ain’t over ‘til it's over’. Trends Cell Biol 10: 147–154.
Toyoshima M, Tanaka N, Aoki J, Tanaka Y, Murata K, Kyuuma M et al. (2007). Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin. Cancer Res 67: 5162–5171.
van Meeteren LA, Moolenaar WH . (2007). Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46: 145–160.
Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK et al. (2005). LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435: 104–108.
Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ et al. (1998). Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424–2433.
Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M et al. (2000). A genome-wide survey of RAS transformation targets. Nat Genet 24: 144–152.
Acknowledgements
We thank Laurens A van Meeteren for LPA receptor plasmids and advice, Wendy Lagcher for technical assistance and Nullin Divecha and Daniel S Peeper for helpful discussions. This study was supported by grants from the Dutch Cancer Society, NKI 2003-2935 (to MvL) and NKI 2003-2964 (to WHM).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Taghavi, P., Verhoeven, E., Jacobs, J. et al. In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. Oncogene 27, 6806–6816 (2008). https://doi.org/10.1038/onc.2008.294
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.294
Keywords
This article is cited by
-
Role of autotaxin in cancer stem cells
Cancer and Metastasis Reviews (2018)
-
Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer
Oncogene (2016)
-
New insights into signalling-pathway alterations in rhabdomyosarcoma
British Journal of Cancer (2015)
-
Lysophosphatidic acid rescues bone mesenchymal stem cells from hydrogen peroxide-induced apoptosis
Apoptosis (2015)
-
Insights into autotaxin: how to produce and present a lipid mediator
Nature Reviews Molecular Cell Biology (2011)